Literature DB >> 12237875

Detection of three common translocation breakpoints in non-Hodgkin's lymphomas by fluorescence in situ hybridization on routine paraffin-embedded tissue sections.

Eugenia Haralambieva1, Karin Kleiverda, David Y Mason, Ed Schuuring, Philip M Kluin.   

Abstract

Non-random chromosomal translocations are specifically involved in the pathogenesis of many non-Hodgkin's lymphomas and have clinical implications as diagnostic and/or prognostic markers. Their detection is often impaired by technical problems, including the distribution of the breakpoints over large genomic areas. This study reports a fluorescence in situ hybridization (FISH) method which allows the detection of specific chromosomal breakpoints in tissue sections from routinely fixed, paraffin-embedded samples. Hybridization was performed after demasking the DNA. Previously validated locus-specific probes (cosmids, PACs) flanking the BCL1, BCL2 regions and similar new probes for the MYC breakpoint region were used. The cases studied were five mantle cell lymphomas (MCL) and five follicular lymphomas (FL), selected on the basis of a previously proved t(11;14) and t(14;18) and five randomly chosen Burkitt's lymphomas (BL), as well as 21 negative control samples. In all samples, hybridization signals of sufficient intensity were obtained. Three different algorithms were used to score the hybridization signals in tissue sections, two of them taking into account the nuclei and their signal distribution indicative of chromosomal break, and one only considering the colocalization or segregation of the signals. In control tissues, these algorithms resulted in cut-off levels of 9.1%, 1.3%, or 10.0%. In the 15 lymphoma samples the percentages of abnormal cells/signals ranged from 28% to 80%, 13% to 49%, and 40% to 70%, respectively. The results indicate that small locus-specific probes can be used in FISH for regular detection of translocation breakpoints on routine paraffin tissue sections. Copyright 2002 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2002        PMID: 12237875     DOI: 10.1002/path.1197

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  19 in total

1.  MYC+ diffuse large B-cell lymphoma is not salvaged by classical R-ICE or R-DHAP followed by BEAM plus autologous stem cell transplantation.

Authors:  Wendy Cuccuini; Josette Briere; Nicolas Mounier; Hans-Ullrich Voelker; Andreas Rosenwald; Christer Sundstrom; Sergio Cogliatti; Edouard Hirchaud; Loic Ysebaert; Dominique Bron; Jean Soulier; Philippe Gaulard; Remi Houlgatte; Christian Gisselbrecht; Catherine Thieblemont
Journal:  Blood       Date:  2012-03-09       Impact factor: 22.113

2.  Standardised fluorescence in situ hybridisation in cytological and histological specimens.

Authors:  Ludwig Wilkens; Heidrun Gerr; Dorothea Gadzicki; Hans Kreipe; Brigitte Schlegelberger
Journal:  Virchows Arch       Date:  2005-06-10       Impact factor: 4.064

3.  Myelodysplasia Cutis Versus Leukemia Cutis.

Authors:  A Osio; M Battistella; J-P Feugeas; W Cuccuini; M-E Noguera; T Petrella; E Raffoux; A Janin; Vignon Pennamen
Journal:  J Invest Dermatol       Date:  2015-05-10       Impact factor: 8.551

Review 4.  FISH analysis for the detection of lymphoma-associated chromosomal abnormalities in routine paraffin-embedded tissue.

Authors:  Roland A Ventura; Jose I Martin-Subero; Margaret Jones; Joanna McParland; Stefan Gesk; David Y Mason; Reiner Siebert
Journal:  J Mol Diagn       Date:  2006-05       Impact factor: 5.568

5.  Differences between BCL2-break positive and negative follicular lymphoma unraveled by whole-exome sequencing.

Authors:  A Zamò; J Pischimarov; M Schlesner; P Rosenstiel; R Bomben; H Horn; T Grieb; T Nedeva; C López; A Haake; J Richter; L Trümper; C Lawerenz; W Klapper; P Möller; M Hummel; D Lenze; M Szczepanowski; L Flossbach; M Schreder; V Gattei; G Ott; R Siebert; A Rosenwald; E Leich
Journal:  Leukemia       Date:  2017-08-21       Impact factor: 11.528

6.  Follicular lymphoma grade 3B is a distinct neoplasm according to cytogenetic and immunohistochemical profiles.

Authors:  Heike Horn; Christopher Schmelter; Ellen Leich; Itziar Salaverria; Tiemo Katzenberger; M Michaela Ott; Jörg Kalla; Monica Romero; Reiner Siebert; Andreas Rosenwald; German Ott
Journal:  Haematologica       Date:  2011-06-09       Impact factor: 9.941

7.  MicroRNA profiles of t(14;18)-negative follicular lymphoma support a late germinal center B-cell phenotype.

Authors:  Ellen Leich; Alberto Zamo; Heike Horn; Eugenia Haralambieva; Bernhard Puppe; Randy D Gascoyne; Wing-Chung Chan; Rita M Braziel; Lisa M Rimsza; Dennis D Weisenburger; Jan Delabie; Elaine S Jaffe; Jude Fitzgibbon; Louis M Staudt; Hans-Konrad Mueller-Hermelink; Mariarita Calaminici; Elias Campo; German Ott; Luis Hernández; Andreas Rosenwald
Journal:  Blood       Date:  2011-09-29       Impact factor: 22.113

8.  Similar clinical features in follicular lymphomas with and without breaks in the BCL2 locus.

Authors:  E Leich; E Hoster; M Wartenberg; M Unterhalt; R Siebert; K Koch; W Klapper; M Engelhard; B Puppe; H Horn; A M Staiger; C Stuhlmann-Laeisz; H W Bernd; A C Feller; M Hummel; D Lenze; H Stein; S Hartmann; M L Hansmann; P Möller; W Hiddemann; M Dreyling; G Ott; A Rosenwald
Journal:  Leukemia       Date:  2015-12-01       Impact factor: 11.528

9.  Double-staining chromogenic in situ hybridization as a useful alternative to split-signal fluorescence in situ hybridization in lymphoma diagnostics.

Authors:  Anke van Rijk; Tim Svenstroup-Poulsen; Margaret Jones; José Cabeçadas; Juan Cruz Cigudosa; Lorenzo Leoncini; Anja Mottok; Christiane Copie Bergman; Evi Pouliou; Stephen Hamilton Dutoit; Han J van Krieken
Journal:  Haematologica       Date:  2009-09-22       Impact factor: 9.941

10.  Mantle cell lymphoma: improved diagnostics using a combined approach of immunohistochemistry and identification of t(11;14)(q13;q32) by polymerase chain reaction and fluorescence in situ hybridization.

Authors:  Roman Kodet; Marcela Mrhalová; Lenka Krsková; Jan Soukup; Vít Campr; Tomás Neskudla; Peter Szépe; Lukás Plank
Journal:  Virchows Arch       Date:  2003-05-01       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.